Friday, March 20, 2020

TRUMP IS AN IDIOT
Analysis: Seven days as a ‘wartime president’: Trump’s up-and-down command of a pandemic

Philip Rucker, Ashley Parker 


President Trump was reeling from one of his worst weeks ever: The novel coronavirus was killing Americans, wrecking the economy and subsuming him and his presidency.

But in the pandemic, Trump saw an opportunity to cast himself in a new role: “Wartime president,” as he later dubbed it. Aides noted that Trump was punctual for last Saturday’s White House task force meeting, donning a navy “USA” cap and — instead of simply watching as Vice President Pence and the assembled health officials briefed the public that afternoon, as he’d initially planned — joining them at the rostrum.

All week, Trump reveled in his newfound character — that of a crisis commander steering his skittish nation through battle with what he called an “invisible enemy.” He parried questions, barked orders and stood stoically by as he accepted praise, day after day, from his underlings for his “strong leadership” and “decisive actions.”

But on Friday, Trump faltered. He argued based on “just a feeling” that, despite no scientific evidence yet, an anti-malaria drug could cure the coronavirus. He complained that he has not been credited for fixing a nationwide testing system that clearly is still broken. And when asked what message he had for Americans who were scared, he lashed out.

“I say that you’re a terrible reporter,” Trump answered to NBC News correspondent Peter Alexander. “That’s what I say.”

Trump’s past seven days at the helm of the coronavirus effort illuminated his mercurial nature and underscored his difficulty overseeing the national response to a global catastrophe largely out of his — or any other leader’s — control.

Trump — whose moods often determine policy and are almost directly correlated to the vagaries of 24-hour news cycles — has been lapsing into his self-destructive ways even when aides stress the importance of steady leadership during a national emergency.

Fixated on his portrayal in the media, Trump has used this past week to try to rewrite history in hopes of erasing the public’s memory of him dismissing the severity of threat and bungling the early weeks of the administration’s response.

“I’ve felt that it was a pandemic long before it was called a pandemic,” Trump said Tuesday. Only five days earlier he had declared, “It’s going to go away,” and two days before that he had said, “It will go away. Just stay calm.”



1/5 SLIDES © Jabin Botsford/The Washington Post

After the coronavirus was first detected in China and swept across Europe, and even after the first reported case in the United States on Jan. 21, Trump tried to wave off the danger. He was then in the throes of the impeachment battle and distracted by the Democratic presidential primaries. The president accused the media of perpetuating a hoax, arguing that news organizations were drumming up hysteria over the growing public health crisis as a way to hurt his presidency.

The nadir for Trump came March 6, when he visited the Centers for Disease Control and Prevention headquarters in Atlanta and appeared to make a mockery of the scientists’ warnings. He then decamped for the extended weekend to Palm Beach, Fla., where he played golf and hung out with friends at his Mar-a-Lago Club, which itself turned into a coronavirus petri dish.

Trump’s public posture began to shift, however, once the financial markets started to plummet. He was particularly taken with the numbers — not just the cratering Dow Jones industrial average but also the briefings he received from Vice President Pence, multiple times a day, with fresh data and figures showing how the virus could devastate the nation if left unchecked.

A new study released earlier this week by the Imperial College London — which projected that 2.2 million would die in the United States alone if no steps were taken to curb the outbreak — was particularly influential among Trump’s inner circle.

Trump also was influenced by his conversations with business leaders and wealthy supporters, who lit up the presidential phone line with angst and alarm over the Wall Street meltdown. Their message: Get it together. The world’s collapsing and you’re flaunting that you don’t care.


Trump then took a series of steps in quick succession to try to gain control over the spiraling crisis. He delivered a prime-time address to the nation. He banned travel from Europe. And he declared a national emergency.

Though Trump claims his Jan. 31 restrictions on travel from China as evidence that he always has taken the coronavirus seriously, one senior White House official said his March 11 announcement prohibiting most travel from countries in the European Union — a critical diplomatic ally and trade partner — helped truly underscore for Trump the severity of the crisis.

Trump was angry that his error-riddled prime-time Oval Office address to the nation, in which he announced the Europe ban, was widely panned, and frustrated that so few allies defended him on television the next day. But on March 13, a news conference in the Rose Garden — at which he announced a new testing website and new testing locations, both of which were half-baked at best — buoyed his spirits because he finally felt he had at least the illusion of control, aides said.

Officials also pointed to Hope Hicks — Trump’s former communications director and close confidante who recently returned to the White House after a stint in Los Angeles — as a calming presence who helped focus Trump.

Each day after the task force meets and before members present their latest message to the public, a small group retreats to the Oval Office to strategize about the news conference. The group includes whatever officials are speaking that day, as well as Pence, Hicks, White House chief of staff Mark Meadows, the vice president’s chief of staff Marc Short, and Trump’s son-in-law and senior adviser Jared Kushner. Hicks often offers tonal suggestions, helping steer Trump toward the sort of more measured language that his advisers have long been pushing.

On Monday, Trump adopted the far more serious tone that his advisers had encouraged. He echoed the guidance of infectious disease experts and offered direction about what people should and shouldn’t do. He advised against gatherings of more than 10 people, as well as discretionary travel, and urged whoever could work from home to do so. He even hit the pause button on his various feuds with Democrats and the media.

“My focus is really on getting rid of this problem — this virus problem,” he said Monday. “Once we do that, everything else is going to fall into place.”

Trump spoke of the coronavirus as if it were a foreign adversary at war, drawing parallels between the ways Americans are adapting their lives to adhere to social distancing guidelines to the sacrifices citizens made during World War II. Speaking about his own leadership, Trump said Wednesday, “I view it as, in a sense, a wartime president.”

Historian Michael Beschloss said Trump’s conception of himself as a wartime leader is potentially apt.

“The war metaphor is actually a good one if what it means is that the president is acting as a commander in chief does, which is trying to orchestrate all of the power of the federal government to solve the problem and to level with the American people,” Beschloss said. “But this is not a war against a foreign enemy. It is not military. Waging a war is not the same thing as fighting an illness.”

The president’s resolve, however, did not last. Trump has never demonstrated the ability to sustain discipline or message control over an extended period — frequently following fleeting periods of calm with bursts of seeming self-sabotage — and this week was no different.

On Thursday, Trump snapped at a reporter who began a question by stating that “the economy is essentially ground to a halt.”

“Thanks for telling us — we appreciate it,” Trump said, before adding, “Everybody in the room knows that.”

By Friday, Trump was in full tirade mode. Seemingly desperate for a miracle medicine, he kept on pushing an anti-malarial drug as a potential cure-all, prompting Anthony S. Fauci, the director for the National Institute of Allergy and Infectious Diseases, to gently offer a more nuanced view.

But even the normally placid-faced Fauci could barely contain himself when Trump referred to “the State Department or, as they call it, the ‘Deep State’ Department.” Fauci, standing just behind Trump’s left shoulder but still on camera, smirked and touched his fingertips to his brow to cover his face as he struggled to suppress a chuckle.

Other moments were less humorous. When Alexander, the NBC reporter, asked Trump what message he had for “Americans who are watching you right now who are scared,” Trump angrily attacked him as “a terrible reporter” and called it “a very nasty question.”

When Alexander later posed the same question to Pence, it was Trump’s No. 2 who offered the words one might ordinarily expect from a wartime president: “Don’t be afraid. Be vigilant.”


 


 Analysis: Trump's coronavirus claims haven't matched response reality

WASHINGTON — To hear President Donald Trump tell it, there is a website where you can find out if you need to get tested for coronavirus, and millions of testing kits available for anyone who needs one. There is an approved treatment, a vaccine coming soon, plenty of protective masks in circulation, and a ship that will be off the coast of New York next week to help patients.

But the president's description of the state of measures being taken by his administration stands in sharp relief to the reality being described by the experts on the ground involved in the response. And so the president, who was criticized early in the crisis for downplaying the risk posed by the virus while health officials were sounding the alarm, now faces claims that he is overplaying the available assistance.

While Trump has given overly optimistic timelines and overstated his accomplishments throughout his time in office, in the case of the coronavirus pandemic, his alternate version of events threatens to create unnecessary confusion among the public, potentially leading to a false sense of security, drawing criticism from public health experts and political opponents.

"Memo to Donald Trump: take a day off from the briefing room where you hype cures that aren't proven, promise websites that don't exist, and talk about tests that aren't being given -- and let @CDCgov talk," Ron Klain, a longtime adviser to Democratic presidential contender Joe Biden who led the Obama administration's response to the Ebola outbreak, said Thursday in a tweet.

The president has gone further than government experts on multiple fronts, including available treatment.

On Thursday — during a news conference which Trump had described a day earlier as being held to announce "very important news from the FDA concerning the Chinese Virus!" — he said a decades-old malaria drug had been approved to treat COVID-19 and could be a "game changer." Moments later, the FDA said the drug was still going through the approval process to determine if it was safe and effective for coronavirus patients.

When Trump was pressed by NBC's Peter Alexander on Friday about whether this claim was giving Americans false hope, he testily defended his positive spin. "I feel good about it, that's all, just a feeling, smart guy," Trump said. "I feel good about it, and you are going to see soon enough."

Trump's recent assurances about the scope of medical supplies on the way for health care workers also hasn’t matched what has been available on the ground.

As hospitals have scrambled to get the protective supplies they need, Trump has repeatedly expressed confidence the U.S. will have the supplies needed. Over the past week, Trump has said the U.S. had “massive numbers of ventilators” and plenty of protective masks for health care workers while assuring that more supplies were on the way.

“The masks are being made by the millions,” Trump said on March 14. “Millions and millions. We have plenty now, but we're ordering for the millions. We're ordering worst-case scenario.”

But a few days later, Trump had to call on the military to rush out protective supplies, as hospitals said they had to start reusing masks, making their own and asking the public for donations.

When Trump was asked at a press briefing Thursday about the gap between his own claims and what health care providers say they are experiencing, he denied over-hyping. “I’m hearing very good things on the ground," he said.

To make sure the U.S. has the supplies it needs, Trump said Wednesday he was turning to the Defense Production Act, to get the private sector to ramp up production, similar to the effort in WWII when factories adapted their capabilities to make military equipment. But Trump declined to specify on Friday what steps, if any, he had taken under the act to require companies to ramp up production of needed supplies.

For patients confused about whether they need testing and how to get it, Trump announced last week that Google was developing a coronavirus testing website that was going to be “very quickly done, unlike websites of the past.” Vice President Mike Pence said Americans would be able to use the website “very soon” to find out if they needed testing and where to go to get it.

But the website being developed by Google sister company Verily has ended up being much more limited in scope than what the White House promised. Verily did launch a website this week similar to the one Trump described, but said in a statement to NBC News that the site is in the “early stages of development” and only being tested in two California counties.

While Pence clarified the day after the White House announced the site that it would just be for the San Francisco Bay Area, “with the goal of expanding to other locations,” Trump denied there was any miscommunication, saying the head of Google called to apologize, without elaborating on what that apology was allegedly for, and accused the media of putting out false information, without specifying what the inaccuracies might be.

To address growing concerns by hospitals that they would soon run out of beds for patients, Trump said at a Wednesday press conference that the Navy was sending a medical ship to New York and another to the West Coast to help treat patients. Trump said the ships “are in tip-top shape. They soon will be.” On timing, he said “they can be launched over the next week or so, depending on need.”

Defense Secretary Mark Esper gave a less optimistic timeline later that day. During an interview on CNN, he said the ship to be sent to New York, which is currently undergoing maintenance, wouldn’t be ready for “a couple weeks plus” and the one on the West Coast “should be ready in a week and half, two weeks, definitely before the end of the month.” He said the ships still needed to be staffed with medical personnel, and only then moved to their locations.

Esper also clarified that the ships, built to deal with wartime trauma, wouldn’t be used to treat those infected with the coronavirus, but rather to take care of other patients to free up hospital operating rooms.

And as concern has mounted in the general public over exposure and diagnosis, Trump has repeatedly overplayed the availability of testing. He said on March 6 that anyone who needed a test was able to get one, reiterating that claim when asked about it at a press conference last week. On March 9, Vice President Mike Pence said that 1 million tests had been distributed, and 4 million more were expected to be sent by the end of the week, predicting on March 13 that 15,000 to 20,000 tests would be performed a day.

The testing availability has been changing rapidly and more labs are coming online daily, but roughly eight weeks after the first confirmed cases, roughly 112,000 tests have been conducted, according to researchers at the COVID Tracking Project. Doctors have continued to say they struggle to obtain testing and results for patients they believe should be tested.

On Friday, Trump said again that the administration was not getting proper praise for the actions he had taken. "We haven’t been given the credit we deserve," the president told reporters. "That I can tell you."



Goldman Sachs CEO gets 19% raise, bumping his pay to $27.5 million

IMAGINE IF A UNION ASKED FOR A 19% RAISE FOR ITS MEMBERS

THE HOWLING OF WALL ST. AND BAY ST. WOULD BE DEAFENING

Goldman Sachs releases 2019 compensation numbers

Goldman Sachs CEO David Solomon received a 19% raise for his work in 2019, a filing issued on Friday shows.

The increase bumps his pay to $27.5 million for 2019, up from $23 million for his work in 2018.

Solomon's 2019 compensation includes a $1.9 million base salary, a $7.7 million cash bonus, and a $17.8 million stock bonus, according to the filing.


Goldman Sachs said in the filing that Solomon "successfully executed on his priorities in his first full year as Chairman and CEO," and "demonstrated a strong commitment to improved transparency," among other "performance achievements."

Solomon became CEO of Goldman Sachs in 2018, replacing Lloyd Blankfein.

A spokesperson for Goldman Sachs was not immediately available for comment.


California earthquake: Massive 5.2 quake rocks US striking just off the coast

A MASSIVE earthquake has rocked the US, just off the Californian coast, with a 5.2 Richter scale reading.

By REBEKAH EVANS PUBLISHED: Thu, Mar 19, 2020

The news follows a March forecast which predicted California could experience a big earthquake within weeks.

A "major seismic hazard" - the Rose Canyon fault - has been recorded beneath California's San Diego, which was estimated at the time to cause $38 billion of damage.

The Richter scale, used to measure the strength of earthquakes, was developed by US seismologist Charles F. Richter in 1935.

The reading was first recorded by the United States Geological Survey - a scientific agency of the US government.
The San Andreas fault line lies along California, causing regular quakes (Image: GETTY)

At the time, the Earthquake Engineering Research Institute warned of the fault lines.
They said: "San Diego could suffer major geologic ground failure and ground shaking hazards resulting in severe seismic damage consequences."

This particular earthquake only sent shockwaves to mainland America.

But it could be a sign of developments to come.

READ MORE: California earthquake: Is Big One coming? ‘Major hazard’ threat

The earthquake registered at 5.2 on the Richter Scale (Image: USGS)

The National Weather Service’s Tsunami Warning System said there was no risk of a tsunami from the earthquake last night.

According to the US Geological Survey, Wednesday’s quake had its epicenter under the Pacific Ocean about 35 miles southwest of Eureka and fewer than 10 miles offshore.

Almost 100 Eureka resident had posted online reports to the Geological Survey saying they’d felt shaking.

It comes after another quake on March 8, which was measured at a magnitude of 5.8, with an epicenter 70 miles southwest of Eureka.
Shockwaves reached mainland USA (Image: USGS)

During this earthquake, the epicenter was more than a mile deep beneath the Pacific Ocean and about 70 miles southwest of Eureka, the agency reported.

It had earlier reported the magnitude as 5.9, but downgraded it slightly later on Sunday night.

The National Weather Service’s US Tsunami Warning System said there was no danger of a tsunami from the temblor.

This is because it was centered west of Petrolia, a town about 45 miles south of Eureka

California is often struck by earthquakes.

This is because the state is home to the San Andreas fault line, which is overdue another Big One.

The last Big One struck on April 18, 1906, off the northern California coast.

It is believed to have killed 3,000 people.

RELATED ARTICLES

Italy volcano: WATCH Stromboli shoots lava as earthquake hits Calabria

Utah earthquake: Huge 5.7 magnitude quake rocks Salt Lake City

COVID-19 PIC OF THE DAY


L’Oréal Announces Plans to Produce Hand Sanitizer in Response to the Shortage


SO FAR IT IS ALL FRENCH PERFUMERS AND AN IRISH GIN COMPANY,
WHERE IS COTY, AVON, REVLON, AND OTHER AMERICAN COMPANIES?

Kaleigh Fasanella
© Getty Images

As a direct result of the COVID-19 outbreak, hand-sanitizing products are becoming increasingly difficult to come by. In response to the shortage, L'Oréal Group, one of the world's biggest beauty producers, has announced it will use its manufacturing facilities to make hand sanitizer and hydroalcoholic gel to distribute throughout Europe, reports Women's Wear Daily.

The Foundation L’Oréal also announced its plans to donate one million euros to the associations that are working around the clock to help the disadvantaged during these unprecedented (and uncertain) times. According to WWD, this involves distributing money to several associations, as well as offering the beneficiaries, social workers, and volunteers who work at those associations hygiene kits and hydroalcoholic gel to help prevent furthering the spread.

The beauty brand's chairman and chief executive officer, Jean-Paul Agon, told WWD: "In this exceptional crisis situation, it is our responsibility to contribute in every possible way to the collective effort. Through these gestures, L’Oréal wishes to express its appreciation, support, and solidarity with all those who mobilize with extraordinary courage and abnegation to fight against this pandemic."

In addition, L'Oréal is putting a hold on all debts owed to them by small and medium-sized businesses as a result of the situation. And for the businesses that are experiencing the most devastation, it will set up a personalized payment system that reflects their specific situation.

L'Oréal isn't the only beauty company putting forth efforts to help those impacted by the coronavirus crisis. LVMH, the French giant behind luxury brands like Louis Vuitton and Givenchy, recently announced it would use all of its perfume and cosmetics facilities to manufacture and distribute hand sanitizer during this time.

"Given the risk of shortage of hydroalcoholic gel in France, Bernard Arnault has instructed the LVMH Perfumes and Cosmetics business to prepare its production sites to manufacture substantial quantities of hydroalcoholic gel to be provided to public authorities," said the company in a statement obtained by WWD.


SEE
https://plawiuk.blogspot.com/2020/03/iconic-distilleries-turn-to-hand.html
https://plawiuk.blogspot.com/2020/03/loreal-announces-plans-to-produce-hand.html
https://plawiuk.blogspot.com/2020/03/from-vodka-and-gin-to-hand-sanitizer.html
https://plawiuk.blogspot.com/2020/03/dior-and-givenchy-to-use-perfume.html
https://plawiuk.blogspot.com/2020/03/he-has-17700-bottles-of-hand-sanitizer.html
https://plawiuk.blogspot.com/2020/03/new-yorks-solution-to-hand-sanitizer.html

TRUMP LIES
Fauci throws cold water on Trump's declaration that malaria drug a 'game changer'

Trump on malaria drug for COVID-19: ‘I feel good about it’


A day after President Donald Trump declared an anti-malaria drug a “game changer” in the fight against the novel coronavirus, the nation’s top infectious disease expert downplayed any role it might play in the fast-moving pandemic and said signs of the drug’s promise were purely “anecdotal.”

Fauci’s statements at a White House briefing Friday amounted to clinical cold water thrown on the president’s repeated upbeat assessments on the U.S. fight against the virus, also known as COVID-19.

Trump has falsely declared in recent weeks that anyone who wants a test could get one, despite limited access in parts of the country that continued through this week.

On Thursday, Trump declared an anti-malaria drug called chloroquine a “game changer” in the effort to develop a coronavirus treatment and announced the drug had been “approved.”

Chloroquine, or hydroxychloroquine, has been approved to treat and prevent malaria since 1944. But no drug has been approved to treat COVID-19, and a vaccine is estimated to remain at least a year away.MORE: Chloroquine, an old malaria drug, may help treat novel coronavirus, doctors say 
Donald Trump in a suit and tie: Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks during a briefing on the latest development of the coronavirus outbreak in the U.S. at the White House, March 20, 2020, in Washington.

© Jim Watson/AFP via Getty Images Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, speaks during a briefing on the latest development of the coronavirus outbreak in the U.S. at the White House, March 20, 2020, in Washington.When asked if the drug was promising Friday, Fauci, standing next to Trump, said “the answer is no” because “the evidence you’re talking about … is anecdotal evidence.”

“The information that you’re referring to specifically is antecdotal,” he added. “It was not done in a controlled clinical trial. So you really can’t make any definitive statement about it.”

Trump then stepped forward to add: “We’ll see. We’re going to know soon.”

The president then repeated his assessment that the drug was potentially a “game changer” and said: "We have millions of units ordered.”

MORE: Trump announces potential 'game changer' on drugs to treat novel coronavirus, but FDA says more study is needed 

When asked if he was giving the nation a false sense of hope, Trump said no.

“It may work, it may not work,” he said. “I feel good about it.”

On chloroquine, U.S. health officials say it’s possible that doctors could try the drug to treat coronavirus symptoms if it’s already on the market. Clinical trials are under way.

But the FDA says it wants to study the potential of the drug before recommending its use, in part so that patients and their doctors don’t waste critical time on a drug that might not work.

On testing, Fauci said it’s true that not everyone who wants a test can get one.

He said access to tests has improved in recent days noticeably, with the private sector having jumped on board.

But, he added, he continues to hear from people unable to determine if a patient has been infected – a serious problem when trying to mitigate the spread.

“I understand and empathize with the people who rightfully are saying I’m trying to get a test and I can’t,” Fauci said.

A reporter asked: “So is that another way of saying we are not at a point where we are meeting the demand pressure?”

“The answer is yes … We are not there yet because otherwise people would never be calling up saying they can’t get a test,” he said.

Fauci and Trump agreed that people without symptoms don’t need to tested. And Fauci said even without testing, communities can respond to the outbreak by limiting social contact.

“Testing is important. It would be nice to know. And there are certain things you could do” with results, Fauci said. “But let’s not conflate testing with the action we have to take,” which includes social distancing and washing hands.


TRUMP IS AN IDIOT
Virus Drug Touted by Trump, Musk Can Kill In Just Two Grams
China recommended chloroquine for coronavirus a month back

Within days, it cautioned against severe side effects


‘It’s not going to kill anybody,’ Trump says at White House

Research still examining safety, effectiveness of chloroquine


(Bloomberg) -- The drug touted by the U.S. President Donald Trump as a possible line of treatment against the coronavirus comes with severe warnings in China and can kill in dosages as little as two grams.

China, where the deadly pathogen first emerged in December, recommended the decades-old malaria drug chloroquine to treat infected patients in guidelines issued in February after seeing encouraging results in clinical trials. But within days, it cautioned doctors and health officials about the drug’s lethal side effects and rolled back its usage.

This came after local media reported that a Wuhan Institute of Virology study found that the drug can kill an adult just dosed at twice the daily amount recommended for treatment, which is one gram.

As the drug hasn’t been approved by the U.S. Food And Drug Administration to treat the disease known as Covid-19, the Chinese experience may be useful as the American regulator studies the medication which has been endorsed by Trump as well as Tesla Inc. chief executive officer Elon Musk.

© Photographer: Barcroft Media/Barcroft Media An employee checks the production of chloroquine phosphate, resumed after a 15-year break, in a pharmaceutical company in Nantong city in east China's Jiangsu province Thursday, Feb. 27, 2020.

The pandemic, which has sickened more than 235,000 globally and killed over 9,800 people, has triggered growing anxiety across the U.S. as states say they lack testing kits and medical equipment. California instituted a state-wide lockdown on Thursday to slow the outbreak.

Chloroquine was among the first group of therapies Chinese scientists identified as being effective in curbing the new coronavirus. Clinical trials on about 130 patients demonstrated the drug’s ability to reduce the severity of the illness and speed up virus clearance, according to China’s Ministry of Sciences and Technology.

Chroloquine phosphate was officially recommended on Feb. 19 in the Covid-19 treatment guidelines published by China’s National Health Commission, along with a few other drugs such as AbbVie Inc.’s Kaletra and flu drug arbidol as antiviral treatments for patients. The commission recommended no more than a 10-day course of chloroquine for adult patients at 500mg -- half a gram -- twice a day.


The Search for New Drugs for Coronavirus Faces Long Odds

As hundreds of clinical trials are launched to study potential Covid-19 treatments, stocks of drugmakers and biotechnology companies have racked up big gains on the hope that the industry will see a windfall. But the history of previous viral outbreaks like Ebola and Zika show little success in producing viable treatments. Some potential drugs were developed only after the epidemics already waned through containment measures.
Closely Watched

China’s recommendation to use chloroquine in treatment was quickly followed by a warning.

Two days after the treatment guideline update, health authorities in Hubei province -- China’s worst-hit region where the outbreak started and which accounted for majority of its over 80,000 patients -- asked hospitals to closely watch for, and immediately report, any adverse side effects of chloroquine phosphate, according to a report in local media outlet The Paper.

The drug is known to have short-term side effects such as nausea, diarrhea and tinnitus while long-term use can irreversibly impair eyesight. It’s forbidden for pregnant women as it can cause congenital defects in babies.

China Health Commission revised the dosage in a Feb. 29 notice tightening chloroquine use. The drug cannot be given to pregnant women, those with heart disease, terminal liver and renal disease, retina and hearing loss and patients on antibiotics such as azithromycin and steroid.

It can now be given only to patients between 18 to 65 years of age for a seven-day treatment course. Patients weighing over 50 kilograms (110 pounds) can take 500mg twice a day -- the usual dose -- while those weighing less will be administered the drug just once a day after two days of use, according to the latest guidelines.

A woman in Wuhan proved how lethal chloroquine can be when it’s taken beyond the recommended dose. On Feb. 25, Shanghai-based The Paper reported that she took 1.8 grams of the drug she ordered online after suspecting she had the coronavirus. She did not, but the drug caused her to develop malignant cardiac arrhythmia, which can cause sudden death, and she was admitted to the intensive care unit.
©2020 Bloomberg L.P.


TRUMP IS AN IDIOT
Trump Touts Drug That FDA Says Isn’t Yet Approved for Virus 

By Anna Edney March 19, 2020

‘It’s not going to kill anybody,’ Trump says at White House

Research still examining safety, effectiveness of chloroquine

Trump Says Malaria Drug Approved to Treat Coronavirus


The Food and Drug Administration has been told by President Donald Trump to see if it can expand the use of a decades-old malaria drug as an experimental treatment for coronavirus patients.

The drug, chloroquine, hasn’t yet been approved for treatment of Covid-19, the disease caused by the new coronavirus. While it’s been available for decades for malaria, it’s not clear whether it will work against the new illness. A March 10 review of existing research found there’s little solid proof one way or the other.

During an at-times-confusing White House press conference, Trump said that chloroquine was approved for use and that he wanted to “remove every barrier” to test more drugs against Covid-19 and “allow many more Americans to access drugs that have shown really good promise.”

“Normally the FDA would take a long time to approve something like that, and it’s -- it was approved very, very quickly and it’s now approved by prescription,” Trump said.

An FDA spokesperson said the drug hadn’t been approved for use in Covid-19 patients. However, U.S. doctors are legally able to prescribe a drug for any illness or condition they think is medically appropriate.

More than a dozen generic drugmakers, including Teva Pharmaceutical Industries Ltd.Mylan NV and Novartis AG’s Sandoz unit, manufacture chloroquine, also called hydroxychloroquine. It comes with few major known side effects, is relatively inexpensive and is widely used around the world. It’s also been touted by Tesla Inc. Chief Executive Officer Elon Musk as a potential treatment, and China has been testing it as well.

Mylan said in a statement Thursday it would immediately ramp up manufacturing of hydroxychloroquine pills at its West Virgina facility to meet expected high demand if the medication is shown to be effective against the disease. The generic-drug giant expects to be able to supply the drug by mid-April, ultimately providing 50 million tablets to potentially treat more than 1.5 million patients.

Other drugmakers are also developing experimental treatments and vaccines for Covid-19, with results from a Gilead Sciences Inc. drug, remdesivir, expected next month.

Gilead shares closed down 1.1% at $78.55 in New York, after earlier rising as much as 8.2%.

Press Conference

Trump has called for rules to be relaxed and government authority to be expanded to respond to the coronavirus outbreak, which has resulted in more than 200,000 confirmed cases and at least 9,000 deaths around the globe. Cities have been locked down and economies brutalized as governments try to prevent the spread.

At Thursday’s press conference, Trump and FDA Commissioner Stephen Hahn appeared to differ substantially about the status of the drugs being tested.

Trump said chloroquine had been approved and could be given to patients by doctors with a prescription.

“It’s been around for a long time, so we know that if things don’t go as planned it’s not going to kill anybody,” Trump said.

Shortly thereafter, Hahn said that use of the drug would be in a controlled trial to find out whether or not it works, and if so, what dose would be safe and effective.

“We want to do that in a setting of a clinical trial,” Hahn said.

There was similar confusion over Gilead’s drug, which Trump said was “essentially approved.”

Hahn said afterward that remdesivir is “going through the normal process” and isn’t yet available to patients.


The FDA has increasingly stepped back from its regulatory role in the middle of the crisis, announcing that it would let states regulate tests to diagnose the virus in order to speed their rollout. It has also said it is temporarily halting inspections of drug plants in the U.S. and abroad.

The agency’s standard for drugs is to look at the risk posed by side effects compared with how effective treatments are. But the growing number of coronavirus cases in the U.S., and the lack of any proven therapy or vaccine, may have tilted that balance.
Drug Pipeline

Gilead’s remdesivir was originally developed for use against the Ebola virus. The drugmaker is expected to report early results of tests of the experimental medicine in April.

Regeneron Pharmaceuticals Inc. said Tuesday its development efforts for a drug to treat the virus are ahead of schedule and it could start testing in humans this summer. Several vaccines are also in development.

Even those in Trump’s inner circle have cautioned against equating early research on drugs with proof that they work.

Deborah Birx, a member of the president’s coronavirus task force, said during Wednesday’s White House briefing that Trump had asked for a briefing on potential treatments for the virus. Birx said that even evidence a drug works in animals doesn’t mean it will work in people.

“Of course, there’s always anecdotal reports, and we’re trying to figure out how many anecdotal reports equal real scientific breakthroughs,” Birx said.

A small percentage of people die from infection by the coronavirus, and the vast majority get better on their own as their immune system battles the pathogen. That can make it more challenging to determine whether experimental drugs are effective.

— With assistance by Riley Griffin

(Adds information about Mylan manufacturing in seventh paragraph. An earlier version of this story corrected the number of cases around the globe.)



Early Coronavirus Drug Trials Yield Mixed Results 

By Jason Gale March 19, 2020, 1:04 AM MDT

HIV drug combination shows no benefit in severe patients
 
Fujifilm medicine linked to materially faster viral clearance



Coronavirus Vaccine Test Open
Drug trials on coronavirus patients in China yielded mixed results, with an HIV pill showing little benefit and a flu medication made by Fujifilm Holdings Corp. resulting in faster clearance of the virus.

The combination of lopinavir and ritonavir, marketed by AbbVie Inc. as Kaletra, didn’t improve the condition of severe Covid-19 patients or prevent them from dying more than standard care in a randomized, controlled trial of 199 patients. The research was published Wednesday in the New England Journal of Medicine.

A separate study of 80 patients receiving Fujifilm’s favipiravir, or Avigan, found it helped clear the virus from patients a week earlier than the HIV medicine and was associated with improved chest symptoms shown on CT scans.

The favipiravir study, which wasn’t randomized, was conducted in a different group of patients and at a later time point when doctors might have discovered better ways to care for patients, Evercore ISI analyst Umer Raffat said in a note.

Avigan influenza tablets.Photographer: Akio Kon/Bloomberg

The clinical research on favipiravir augers well for another anti-viral, Gilead Sciences Inc.’s experimental drug remdesivir, which is also undergoing clinical trials in China, Tyler Van Buren, an analyst with Piper Sandler said. Results of the remdesivir study are yet to be published.

“If successful, it could be approved for broad use in the coming months considering it’s safe, the bar for efficacy in the context of the ongoing global pandemic is low,” he said.

Patients in the lopinavir and ritonavir trial were also found to show more gastrointestinal side effects such as vomiting and diarrhea than those not given the drug in the comparison group. Nearly 14% of those taking the drug were unable to finish the 14-day therapy, mostly because of the gastrointestinal disorders.

— With assistance by Michelle Fay Cortez, Cristin Flanagan, and Dong Lyu
TRUMP IS AN IDIOT
Trump rips reporter who asked him to calm scared Americans as 'terrible'

'You're a terrible reporter': Pressed on coronavirus, Trump berates NBC's Peter Alexander

President Donald Trump excoriated an NBC News correspondent as a “terrible reporter” on Friday after he asked the president to calm Americans who were scared because of the coronavirus pandemic.

Trump’s latest personal broadside on the media came at a news conference in which he appeared to minimize the fears of the American public by saying there was cause for optimism about drug therapies for coronavirus — treatments that one of his top government scientists had said were not at all proven.

At the Trump administration's coronavirus task force's daily briefing, Trump’s director of the National Institute of Allergy and Infectious Diseases, Dr. Anthony Fauci, made clear that any evidence about drug therapies being tested at the moment was strictly “anecdotal” and not the product of a “clinical trial.”

“You really can’t make any definitive statement about it,” Fauci said.

Trump nevertheless said he felt "good" about the treatments and that the federal government had already ordered "millions of units" of them.

NBC News’ Peter Alexander then asked Trump whether his “positive spin” regarding the potential treatments was giving Americans false hope.

“Is it possible that your impulse to put a positive spin on things may be giving Americans a false sense of hope?” Alexander asked.

“No I don’t think so,” Trump replied.

“It may work, it may not work, Trump said. “I feel good about. That’s all it is, it’s a feeling.”

Alexander responded by asking Trump to talk directly to Americans who are scared by the pandemic, which triggered the president to reply with an insult.

“What do you say to Americans who are scared, millions who are scared right now?” Alexander asked.

“I say that you’re a terrible reporter,” Trump said. “That’s what I say. I think that’s a very nasty question.”

“You’re doing sensationalism,” Trump said.

U.S. stocks, which had been up for the day before Trump began the news conference, tumbled steadily as the president spoke. In recent trading, the Dow Jones Industrial Average was down more than 100 points, or 0.6 percent.

Trump returned to the topic of media coverage later in the news conference, using another question from another reporter to levy an additional attack on Alexander.

"I’ve dealt with Peter for a long time," Trump said. "And I think Peter is not a good journalist."

TRUMP IS AN IDIOT
Trump Lashes Out at Reporter After Challenge on Unapproved Drug


President Trump calls NBC’s Peter Alexander a “terrible reporter.”


Virus Drug Touted by Trump, Musk Can Kill In Just Two Grams


Trump Touts Drug That FDA Says Isn’t Yet Approved for Virus 


By Josh Wingrove and Jordan Fabian March 20, 2020


President Donald Trump again encouraged Americans to try a malaria drug to fight coronavirus that the FDA hasn’t approved for the disease, and assailed a reporter who suggested that pushing it might spark a false sense of hope.
“I think people will be surprised,” Trump said of the drug, chloroquine, at a White House news conference on Friday. “It will be a game changer.”

NBC correspondent Peter Alexander pointed out that Anthony Fauci, the director of the National Institute of Allergies and Infectious Diseases, has said there is no “magic drug” for the virus and asked whether Trump was providing a “false sense of hope.”

Trump replied: “Such a lovely question. Maybe and maybe not. It may work and it may not work,” he said. “I feel good about it.”

When Alexander then asked what Trump had to say to Americans who are “scared” by the outbreak, Trump grew angry, calling Alexander a “terrible reporter” and saying his question sent “very bad signal.”

“You ought to get back to reporting instead of sensationalism,” he said, adding that “I’ve been right a lot.”

“You ought to be ashamed of yourself,” he added.

When another reporter followed up, asking again what Trump had to say to Americans worried about the virus, Trump said: “There is a very low incidence of death. You understand that,” adding that Americans who contract the disease are very likely to survive.


TRUMP IS AN IDIOT
Sean Spicer debuts as White House reporter during heated Trump coronavirus briefing

© Alex Wong/Getty Images Former White House Press Secretary Sean Spicer sits among members of the press as he waits for the beginning of a news briefing on the latest development of the coronavirus outbreak on Friday.

President Donald Trump heaped scorn on several members of the White House press corps at a coronavirus briefing Friday, but made a point of responding to questions from a new reporter in the briefing room: His former press secretary.

“Mr. President, two questions if you would indulge me,”

Sean Spicer said when Trump pointed a finger to call on his former aid
Spicer, of course, is the former White House and Republican National Committee spokesman who vigorously defended Trump’s inauguration crowd size claims and regularly tangled with reporters during combative White House briefings before his ouster in a 2017 shakeup. He also took a spin on “Dancing With The Stars.”

Spicer now has his own political talk show for the conservative Newsmax TV outlet. By the time Trump entered the White House Briefing Room to address reporters Friday, Spicer was set to press his old boss for presidential reaction to small business anxieties and reports that senators unloaded stocks before a pandemic-sparked market downturn.

The surreal scene played out moments after the president castigated NBC’s Peter Alexander for suggesting that Trump may be giving Americans “a false sense of hope” about coronavirus treatment, asking what he would say to Americans who are scared or sickened by the ongoing COVID-19 outbreak.

“I say that you are a terrible reporter. That's what I say,” Trump told Alexander. “I think that's a very nasty question, and I think it's a very bad signal that you're putting out to the American people. The American people are looking for answers, and they are looking for hope. And you are doing sensationalism.”

Trump’s attacks on the news media are a familiar tactic at his campaign rallies and press conferences. After a brief détente earlier this week, the president lashed out at the media again during Thursday’s briefing. Friday's spat with Alexander, juxtaposed with Spicer’s presence on the other side of the podium, further heightened the strains with the press corps.

Ultimately, Trump used Spicer's questions to praise his administration's response to small businesses hammered by the outbreak and defend senators who reportedly sold stock before markets tanked in response to the pandemic, though he made sure to call out only one of them — a California Democrat — by name.


"I saw some names. I know all of them. I know everyone mentioned," Trump replied to Spicer. "Dianne Feinstein, I guess. And a couple of others. I don't know too much about what it's about, but I find them to all be very honorable people. That’s all I know. And they said they did nothing wrong. I find them — the whole group, very honorable people."
https://plawiuk.blogspot.com/2020/03/watchdog-group-files-complaints-against.html

Friday's exchanges didn't sit well with some other reporters."What the president did to Peter Alexander is reprehensible," CNN anchor John King declared after Friday's press conference.

"It was striking that this came, this, forgive me, bulls*** attack on fake news came just moments after the secretary of State said the American people have to be careful about where they get their information and go to sources they can trust."
Mystery surrounds ‘crazed’ and dying monkeys in Indian state hit by coronavirus

MONKEYS in Indian states hit by coronavirus are dying in mysterious circumstances, leaving vets baffled.


By LAURA O'CALLAGHAN 
PUBLISHED: Fri, Mar 20, 2020 

In the past few days alone eight females and one male have been found dead in the Thrissur district of Kerala, Daily Star Online has reported. Rangers in the area have ruled out Kyasanur Forest Disease (KFD) or monkey fever. A team of experts at the National Institute of Virology in Pune carried out tests.

The animals’ bodies were found in Mele Vettikkattiri near Attoor on Monday.
The state has recently been hit by coronavirus and bird flu.
Vets examined the bodies of the dead animals and found all the females had inflamed uteruses and their stomachs were empty.
Mystery surrounds the deaths of monkeys in an Indian state hit by coronavirus (Image: GETTY)
Monkeys have been dying in mysterious circumstances in an Indian state (Image: GETTY)
This raised fears of an undetermined sexual infection.
Forest vet Dr David Abraham said: “There is a possibility that they would have got the infection from an alpha male monkey of that herd.”
Earlier, four other monkeys were found dead in an orch
Western tourists play with monkeys in India (Image: GETTY)

And two monkeys were seen going “mad” in Puranpur Tehsil in Pilibhit.
One animal bit an official and rangers have stepped up patrols in the vicinity
Teams have been sent to patrol the area around Puranpur railway station, where “a monkey seems to have gone mad, for the last three days”, according to a local ranger.
Monkeys climb across electricity wires in India (Image: GETTY)

He said: “We had found four dead monkeys in a mango orchard at Keshopur village and immediately sent their carcasses for an autopsy.
“Two injured monkeys had been treated at Puranpur range office."
Suspicion is growing that monkeys may have been poisoned by village
Vets have been baffled by the recent spate of events (Image: GETTY)

Dr Rajiv Mishra, deputy chief veterinary officer, said the bodies of the monkeys were sent to the government forensic laboratory in Mathura for testing.
He said: “We are waiting for the report to reach any final conclusion about the reason behind monkeys’ death.” he added.
He said the monkey which was reported to have “gone crazy” near the railway station may have drank toxic water.
Woman Has Touching Reunion With Cat Who'd Been Missing For Years

Nearly four years ago, after a powerful earthquake struck central Italy, an older woman named Dora was among those displaced. But she lost more than just her home.


Amid the chaos and confusion following the disaster, Dora’s beloved cat went missing, never to be seen again.

That is, until recently.

Last week, a person close to Dora took to social media to announce that her long-lost cat had finally reappeared — bringing their many years apart to the happiest of ends.

“Our dear Dora has never stopped looking for him,” Mimma Bei, Dora's friend, wrote. “Who knows where he had have been for so long.”Here’s a video of that heartwarming reunion:

Fortunately, Dora’s cat appeared to be in good physical health despite his long absence. But to be together again, it's plain to see, both their hearts are now complete again, too.

Coronavirus study finds virus can survive for FIVE WEEKS in body after infection
CORONAVIRUS can live in patients for up to five weeks after they first contract the infection, a study has found, questioning current self-isolation measures.

By CALLUM HOARE PUBLISHED: Mar 13, 2020 

The deadly disease has now infected more than 135,000 people worldwide, claiming the lives of almost 5,000 people in the process. Yesterday, Prime Minister Boris Johnson announced fresh plans to tackle COVID-19 in the UK, which included a new seven-day self-isolation measure for those even showing mild symptoms, in order to protect the most vulnerable members of society. The plan is half of the original 14-day suggestion – which the Government now says is for people who have experienced "exposure to a confirmed case but have not shown symptoms".

But, a new study has shown that the deadly virus could linger in patients for more than a month, suggesting it is possible to transmit the virus long after the incubation period noted by the Prime Minister.

The findings, published in The Lancet this week, looked at viral shedding – the length of time the virus can be transmitted after someone is infected.

It was found in one instance to be 37 days after the person contracted the illness and the median duration was 20 days, which is far greater than the maximum 14 days suggested.

It points out: “Prolonged viral shedding provides the rationale for a strategy of isolation of infected patients and optimal antiviral interventions in the future.”

Prolonged viral shedding provides the rationale for a strategy of isolation

Study

Chinese researchers studied 191 patients infected with COVID-19 at Jinyintan Hospital and Wuhan Pulmonary Hospital.

Of the patients, 54 had died from the infection, which remained in their systems until death.


Dr Fei Zhou, of the Peking Union Medical College, wrote: “[The results have] important implications for both patient-isolation decision-making and guidance around the length of antiviral treatment.”

The paper also notes that 48 percent of coronavirus patients had additional health issues, such as hypertension, diabetes and coronary heart disease, which decreased their odds of kicking the virus, along with old age.
 
The Government recommends a seven-day isolation (Image: GETTY)
By comparison, only a third of patients with SARS still harboured the virus in their respiratory tract after as long as four weeks, the Chinese scientists said.

For influenza cases, viral shedding typically persists five to 10 days, beginning within 24 hours before or after the onset of symptoms.

Children and immunocompromised individuals, however, may shed longer – for weeks or months – according to the World Health Organization (WHO).

The UK has now officially moved from the "contain" stage to the "delay" phase now, after the tenth death was confirmed from a total of 590 cases.
The NHS is under strain (Image: GETTY)

Mr Johnson said it was "the worst public health crisis for a generation" and warned many families they would "lose loved ones before their time".

Schools have been advised to cancel trips abroad, while over 70s and those with pre-existing health conditions have been told not to go on cruises.

Mass gatherings have not been cancelled yet, but the Premierl League is to suspend all games until at least April 4.

The Prime Minister said it was important to get the timing right for stricter measures.